View Clinical Trial (Medical Research Study)

An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation - NCT00730171-15213(Clinical Trial 235245)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  Pittsburgh
State:  
PA
Zip Code: 15213
Conditions: Irritable Bowel Syndrome With Constipation - Chronic Constipation
Purpose: The objective of this study is to assess the long-term safety of linaclotide administered to patients with chronic constipation (CC) or irritable bowel syndrome with constipation (IBS-C)
Study summary:
Criteria: Inclusion Criteria: - Sexually active patients of childbearing potential agree to use birth control - Females of childbearing potential must have a negative urine pregnancy test prior to dosing - Lactating females must agree not to breastfeed - Patient must meet protocol criteria for chronic constipation (CC) or irritable bowel syndrome with constipation (IBS-C) Exclusion Criteria: - Patient must not use protocol-defined prohibited medicine - Patient is planning to receive an investigational drug at any time during the study - Patient has an unresolved AE or a clinically significant finding on a physical examination, 12-lead electrocardiogram (ECG), or clinical laboratory test
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: September 9, 2010
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.